Airsonett has been awarded the title MedTech* Company of the Year 2009 in Sweden. The jury consists of MedTech Magazine and IFL at Stockholm School of Economics.
The Jury motivates the choice: “A Swedish company, with roots in Skåne, has with its unique technology developed a prophylactic treatment of allergic asthma and also used the technology for a system which prevents patient infections in the operating environment. The company has consistently built a portfolio of patents and invested in clinical research which has resulted in innovative products in the MedTech field. Moreover the product competes with traditional pharmaceutical treatment for asthma. The company is now working towards an international expansion.”
Airsonett is a research based medical technology company with a unique technology which leads the development of preventative and secondary preventative treatment of allergic asthma as well as management of airborne bacteria and virus contamination.
“We feel very happy and honored to be given this prestigious award. It shows that Airsonett has been recognized also outside our field and that our long term focus on clinical research, product development and registration of patents has given result.” states Dan Kristensson, CEO at Airsonett. “We have a very exciting year ahead of us; among other things, the results of our extensive international, multi-centre study for Protexo will be presented. I would like to take the opportunity to thank Airsonett’s owners for their long term support and the staff for their hard work and dedication, which naturally is a must for Airsonett’s continued development”
* Short for Medical Devices & Equipment
For more information, please contact:
Dan Kristensson, CEO, Airsonett AB, tel:+46 (0)431 40 25 31, e-post dan.kristensson@airsonett.com
For more information about the award and the organization behind it, please visit www.medtechmagazine.se and www.ifl.se.